152 related articles for article (PubMed ID: 16283620)
1. Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines.
French JD; Dunn J; Smart CE; Manning N; Brown MA
Genes Chromosomes Cancer; 2006 Mar; 45(3):277-89. PubMed ID: 16283620
[TBL] [Abstract][Full Text] [Related]
2. De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation.
Chung I; Leonhardt H; Rippe K
J Cell Sci; 2011 Nov; 124(Pt 21):3603-18. PubMed ID: 22045732
[TBL] [Abstract][Full Text] [Related]
3. PML and TRF2 protein expression in hereditary and sporadic colon cancer.
Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z
Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315
[TBL] [Abstract][Full Text] [Related]
4. PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.
Osterwald S; Deeg KI; Chung I; Parisotto D; Wörz S; Rohr K; Erfle H; Rippe K
J Cell Sci; 2015 May; 128(10):1887-900. PubMed ID: 25908860
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.
Jiang WQ; Zhong ZH; Henson JD; Reddel RR
Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460
[TBL] [Abstract][Full Text] [Related]
6. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.
Grobelny JV; Godwin AK; Broccoli D
J Cell Sci; 2000 Dec; 113 Pt 24():4577-85. PubMed ID: 11082050
[TBL] [Abstract][Full Text] [Related]
7. PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells.
Yu J; Lan J; Wang C; Wu Q; Zhu Y; Lai X; Sun J; Jin C; Huang H
Cancer Lett; 2010 May; 291(2):177-86. PubMed ID: 19900757
[TBL] [Abstract][Full Text] [Related]
8. TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies.
Ho A; Wilson FR; Peragine SL; Jeyanthan K; Mitchell TR; Zhu XD
Sci Rep; 2016 Nov; 6():36913. PubMed ID: 27841304
[TBL] [Abstract][Full Text] [Related]
9. Super-telomeres in transformed human fibroblasts.
Chiodi I; Belgiovine C; Zongaro S; Ricotti R; Horard B; Lossani A; Focher F; Gilson E; Giulotto E; Mondello C
Biochim Biophys Acta; 2013 Aug; 1833(8):1885-93. PubMed ID: 23570868
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase IIIalpha is required for normal proliferation and telomere stability in alternative lengthening of telomeres.
Temime-Smaali N; Guittat L; Wenner T; Bayart E; Douarre C; Gomez D; Giraud-Panis MJ; Londono-Vallejo A; Gilson E; Amor-Guéret M; Riou JF
EMBO J; 2008 May; 27(10):1513-24. PubMed ID: 18418389
[TBL] [Abstract][Full Text] [Related]
11. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
Yeager TR; Neumann AA; Englezou A; Huschtscha LI; Noble JR; Reddel RR
Cancer Res; 1999 Sep; 59(17):4175-9. PubMed ID: 10485449
[TBL] [Abstract][Full Text] [Related]
12. Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA.
Stagno D'Alcontres M; Mendez-Bermudez A; Foxon JL; Royle NJ; Salomoni P
J Cell Biol; 2007 Dec; 179(5):855-67. PubMed ID: 18056407
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
[TBL] [Abstract][Full Text] [Related]
14. Telomere maintenance by telomerase and by recombination can coexist in human cells.
Cerone MA; Londono-Vallejo JA; Bacchetti S
Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
[TBL] [Abstract][Full Text] [Related]
15. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.
Draskovic I; Arnoult N; Steiner V; Bacchetti S; Lomonte P; Londoño-Vallejo A
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15726-31. PubMed ID: 19717459
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage.
Ballal RD; Saha T; Fan S; Haddad BR; Rosen EM
J Biol Chem; 2009 Dec; 284(52):36083-36098. PubMed ID: 19797051
[TBL] [Abstract][Full Text] [Related]
17. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
18. hRad21 overexpresses and localizes to the ALT-associated promyelocytic leukemia body in ALT cells.
Zhao B; Wang ZJ; Yi BQ; Ma HC; Xu HM
Cancer Biol Ther; 2010 Jun; 9(12):978-83. PubMed ID: 20364118
[TBL] [Abstract][Full Text] [Related]
19. Human Rif1 protein binds aberrant telomeres and aligns along anaphase midzone microtubules.
Xu L; Blackburn EH
J Cell Biol; 2004 Dec; 167(5):819-30. PubMed ID: 15583028
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
